NEUROPHET, Inc.
Research NEUROPHET, Inc. (380550.KQ) on Bullrun: market cap KRW 74.54B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker380550.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryHealth Information Services
- CurrencyKRW
- Market capKRW 74.54B
- Financial periodQ2 2026
- RevenueKRW 782.42M
- Net income-KRW 5.66B
- Free cash flow-KRW 5.18B
- Gross margin100.0%
Valuation Snapshot
latest market cap is KRW 74.54B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 74.54B | n/a | n/a | n/a |
Dividend history
About NEUROPHET, Inc.
NEUROPHET, Inc., operates as a neuroscience company, engages in the development of medical artificial intelligence solutions in the field of brain science and diseases. The company offers Neurophet AQUA, AI-powered diagnosis assistant software for brain diseases; Neurophet SCALE PET, a software that quantitatively analyzes biomarkers targeted by a specific radiotracer using PET; Neurophet tES LAB, AI-Powered software to generate a 3D model using brain MRI and simulate electrical stimulation for treatment planning;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is NEUROPHET, Inc.'s market cap?
NEUROPHET, Inc.'s market capitalization is KRW 74.54B.
What does NEUROPHET, Inc. do?
NEUROPHET, Inc., operates as a neuroscience company, engages in the development of medical artificial intelligence solutions in the field of brain science and diseases.